DEDD2 antibody (Middle Region)
-
- Target See all DEDD2 Antibodies
- DEDD2 (Death Effector Domain Containing 2 (DEDD2))
-
Binding Specificity
- Middle Region
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This DEDD2 antibody is un-conjugated
-
Application
- Western Blotting (WB)
- Purification
- Purified
- Immunogen
- DEDD2 antibody was raised in rabbit using the middle region of DEDD2 as the immunogen
- Top Product
- Discover our top product DEDD2 Primary Antibody
-
-
- Application Notes
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - Comment
-
DEDD2 Blocking Peptide, catalog no. 33R-7309, is also available for use as a blocking control in assays to test for specificity of this DEDD2 antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Concentration
- Lot specific
- Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- 4 °C/-20 °C
- Storage Comment
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- Target
- DEDD2 (Death Effector Domain Containing 2 (DEDD2))
- Alternative Name
- DEDD2 (DEDD2 Products)
- Background
- DEDD2 may play a critical role in death receptor-induced apoptosis and may target CASP8 and CASP10 to the nucleus. DEDD2 may regulate degradation of intermediate filaments during apoptosis. DEDD2 may play a role in the general transcription machinery in the nucleus and might be an important regulator of the activity of GTF3C3. Synonyms: Polyclonal DEDD2 antibody, Anti-DEDD2 antibody, death effector domain containing 2 antibody, FLAME-3 antibody.
-